Tell your healthcare provider right away about any signs and symptoms of adrenal insufficiency such as: feeling tired or exhausted (fatigue) lack of energy low blood pressure (hypotension) dizziness or feeling faint nausea and vomiting or weakness Reduced adrenal function (adrenal insufficiency).This potentially life-threatening condition can happen when you stop taking oral corticosteroid medicines and start using inhaled corticosteroid medicines (such as QVAR RediHaler).After using your rescue inhaler, contact your healthcare provider right away if you do not get relief from your sudden asthma attacks Worsening asthma or sudden asthma attacks.Rinse your mouth with water without swallowing after using QVAR RediHaler to help prevent an infection in your mouth or throat. Fungal infections (thrush) in your mouth and throat.QVAR RediHaler may cause serious side effects, including:.Tell your healthcare provider about all the medicines you take and about all of your health conditions.Do not use QVAR RediHaler more often than prescribed.Do not use QVAR RediHaler if you are allergic to beclomethasone dipropionate or any of the ingredients in QVAR RediHaler.Always have a rescue inhaler with you to treat sudden symptoms. Do not use QVAR RediHaler to treat sudden severe symptoms of asthma.QVAR RediHaler Inhalation Aerosol is not used to relieve sudden breathing problems and won’t replace a rescue inhaler. QVAR ® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is a breath-actuated inhaled prescription medicine used as a maintenance treatment for the prevention and control of asthma in people 4 years of age and older. If you currently have a prescription for QVAR®, you should speak with your doctor and see if QVAR® RediHaler™ might be right for you.įor additional information, visit Approved Use QVAR® RediHaler™ was also designed to be “spacer-free” (do not use with a spacer) and does not require shaking or priming.įurthermore, effective immediately, QVAR® will no longer be available. That means the medicine is released when you breathe in, eliminating the need for hand-breath coordination during inhalation, a technique commonly associated with standard MDIs. 1 QVAR® RediHaler™ contains the exact same medication as QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol, but utilizes innovative “breath-actuated” inhaler technology. Recent research from the Annals of the American Thoracic Society found that approximately 76 percent of asthma patients struggle to use their metered-dose inhalers (MDIs) correctly. QVAR® RediHaler™ is not used to relieve sudden breathing problems and won’t replace a rescue inhaler. gave up 1.2%.QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now available to patients by prescription! It is the first and only breath-actuated inhaled corticosteroid for the maintenance treatment of asthma in patients ages 4 and older. Teva said the deal should immediately add to its adjusted earnings and would add to its reported earnings within the fourth quarter after closing.įor Teva, the deal expands and diversifies its branded-product portfolio and its R&D capability and provides annual cost synergies of at least $500 million in the third year after closing, the companies said.Īnd further pulling down the bourse were the banks, as Mizrahi Tefahot Bank Ltd.ĭropped 1.7%, Bank Leumi le’Israel BM fell 1.5%, Bank Hapoalim Ltd.ĭropped 1.4%, and Israel Discount Bank Ltd. The Frazer, Pa., biopharmaceutical producer, definitively agreed to be acquired by Teva for $81.50 a share, or $6.8 billion.Ĭephalon earlier this month rejected a bid of $73 a share, or $5.7 billion, from Valeant Pharmaceuticals International Inc. The BlueTech 50 Index of top technology and biomedical stocks eased 0.12% to 286.06.